Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 718 | 1,011 | 637 | 1,037 | 1,540 |
| TOTAL | $943 | $1,258 | $997 | $1,546 | $2,171 |
| Non-Current Assets | |||||
| Intangibles | 470 | 509 | 549 | 588 | 627 |
| TOTAL | $470 | $509 | $549 | $588 | $627 |
| Total Assets | $1,413 | $1,767 | $1,546 | $2,134 | $2,798 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 173 | 254 | 132 | 211 | 185 |
| TOTAL | $266 | $261 | $188 | $351 | $365 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,000 | 1,000 | 0 | 0 | 0 |
| TOTAL | $1,000 | $1,000 | $N/A | $N/A | $N/A |
| Total Liabilities | $1,261 | $1,261 | $188 | $351 | $365 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41 | 41 | 41 | 41 | 41 |
| Common Shares | 20 | 20 | 20 | 20 | 20 |
| Retained earnings | -189,335 | -188,956 | -188,088 | -187,653 | -186,901 |
| TOTAL | $147 | $506 | $1,358 | $1,783 | $2,433 |
| Total Liabilities And Equity | $1,408 | $1,767 | $1,546 | $2,134 | $2,798 |